Hypoxia as a biomarker for radioresistant cancer stem cells
The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Tumor initiation, growth and relapse after therapy are thought to be driven by a population of cells with stem cell characteristics, named cancer stem cells (CSC). The regulation of their radiation resistance and their maintenance is poorly understood. CSC are believed to reside preferentially in special microenvironmental niches located within tumor tissues. The features of these niches are of crucial importance for CSC self-renewal, metastatic potential and therapy resistance. One of the characteristics of solid tumors is occurrence of less oxygenated (hypoxic regions), which are believed to serve as so-called hypoxic niches for CSC. PURPOSE: The purpose of this review was the critical discussion of the supportive role of hypoxia and hypoxia-related pathways during cancer progression and radiotherapy resistance and the relevance for therapeutic implications in the clinic. CONCLUSION: It is generally known since decades that hypoxia inside solid tumors impedes chemo- and radiotherapy. However, there is limited evidence to date that targeting hypoxic regions during conventional therapy is effective. Nonetheless improved hypoxia-imaging technologies and image guided individualized hypoxia targeted therapy in conjunction with the development of novel molecular targets may be able to challenge the protective effect on the tumor provided by hypoxia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Mitochondrial Autophagy Is an HIF-1-dependent Adaptive Metabolic Response to Hypoxia
Zhang, H., Bosch-Marce, M., Shimoda, L. A., Tan, Y. S., Baek, J. H., Wesley, J. B., Gonzalez, F. J., & Semenza, G. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800102200 · Cited by 1,601 · cited 1×
“…under hypoxic conditions and the generation of ROS are inducers of mitophagy, the clearance of mitochondria, which has an additional anti-oxidative and protective eff ect on the malignant cells and is extending cellular life span (Zhang et al. 2008, Zhang and Ney 2009, Ding and Yin 2012).”
BackgroundRetractedLysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
RetractedTargeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717 · cited 1×
“Pre-clinical studies targeting the HIF-1 signaling pathway by genetic or pharmacological means show inhibitory eff ects on tumor growth through repression of angiogenesis, glucose metabolism and hypoxic cancer cell survival (Kung et al. 2000, Chen et al. 2003, Semenza 2003).”
BackgroundJaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535 · cited 1×
“In addition, mitochondrial reactive oxygen species (ROS) are increased under hypoxic conditions and are capable of inactivating PHD enzymes (Jaakkola et al. 2001, Guzy and Schumacker 2006, Chua et al. 2010).”
BackgroundA cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905 · cited 1×
“In addition, HIF decreases the conversion of pyruvate to acetyl-CoA and inhibits the OXPHOS throughout the inhibitory phosphorylation of the pyruvate dehydrogenase (PDH) by the PDH kinase 1 (PDK1) (Kim et al. 2006, Papandreou et al. 2006).”
BackgroundOtto Warburg's contributions to current concepts of cancer metabolism
Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3038 · Cited by 3,427
Targeting hypoxia in cancer therapy
Wilson, W. R., & Hay, M. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3064 · Cited by 3,172
Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype?
Peinado, H., Olmeda, D., & Cano, A. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2131 · Cited by 3,121 · cited 1×
“HIF transcription factors bind promoter regions of EMT marker genes including E-cadherin, vimentin, and N-cadherin (Peinado et al. 2007, Yang and Wu 2008, MarieEgyptienne et al. 2013).”
BackgroundGenes that mediate breast cancer metastasis to lung
Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820 · cited 1×
“…eff ect leading to an accumulation of phosphometabolites and their metabolic derivatives such as P-ribose, nicotine amide adenine dinukleotide phosphat (NADPH) or cytidine triphosphate (CTP), which serve as precursors for amino acid, nucleic acid and lipid synthesis (Christofk et al. 2008a, 2008b).”
BackgroundCellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476 · cited 1×
“Th ese mice are embryonic lethal, because of severe vascular defects, abnormal neural folding and cardiovascular malformation (Maltepe et al. 1997, Iyer et al. 1998, Ryan et al. 1998, Peng et al. 2000).”
BackgroundTumor cell metabolism: cancer's Achilles' heel
Kroemer, G., & Pouyssegur, J. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.005 · Cited by 2,337 · cited 1×
“…cells consume glucose at higher rates and prefer the glycolytic breakdown of glucose for energy production and lactic acid fermentation, rather than the more effi cient glycolysis and mitochondrial oxidation of pyruvate (Warburg 1956, Kroemer and Pouyssegur 2008, Heiden et al. 2009, Dang 2012).”
BackgroundSignal transduction by reactive oxygen species
Finkel, T. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201102095 · Cited by 2,322 · cited 1×
“Moreover, malignant cells reduce oxidative stress through mechanisms of enhanced radical scavenging, e.g., via the glutathione system, alterations of HIF regulatory proteins and the stabilization of HIF-1 (Semenza 2010, Anastasiou et al. 2011, Finkel 2011, Keith et al. 2012).”
BackgroundHIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267
Hypoxia in cancer: significance and impact on clinical outcome
Vaupel, P., & Mayer, A. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9055-1 · Cited by 2,240
Gray, L. H., Conger, A. D., Ebert, M., Hornsey, S., & Scott, O. C. A. (1953) · The British Journal of Radiology · doi:10.1259/0007-1285-26-312-638 · Cited by 2,158
Chandel, N. S., McClintock, D. S., Feliciano, C. E., Wood, T. M., Melendez, J. A., Rodriguez, A. M., & Schumacker, P. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001914200 · Cited by 2,000 · cited 1×
“Th is fi nding is further supported by the fact that in hepatoma cells mitochondria-derived ROS production increases under hypoxia and causes accumulation of the HIF-1 α (Chandel et al. 2000).”
BackgroundInhibitory effect of tumor cell-derived lactic acid on human T cells
Fischer, K., Hoffmann, P., Voelkl, S., Meidenbauer, N., Ammer, J., Edinger, M., Gottfried, E., Schwarz, S., Rothe, G., Hoves, S., et al. (2007) · Blood · doi:10.1182/blood-2006-07-035972 · Cited by 1,946
HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression
Keith, B., Johnson, R. S., & Simon, M. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3183 · Cited by 1,693 · cited 1×
“Moreover, malignant cells reduce oxidative stress through mechanisms of enhanced radical scavenging, e.g., via the glutathione system, alterations of HIF regulatory proteins and the stabilization of HIF-1 (Semenza 2010, Anastasiou et al. 2011, Finkel 2011, Keith et al. 2012).”
BackgroundSalceda, S., & Caro, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22642 · Cited by 1,674
NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α
Rius, J., Guma, M., Schachtrup, C., Akassoglou, K., Zinkernagel, A. S., Nizet, V., Johnson, R. S., Haddad, G. G., & Karin, M. (2008) · Nature · doi:10.1038/nature06905 · Cited by 1,614
HIF‐1α is required for solid tumor formation and embryonic vascularization
Ryan, H. E., Lo, J., & Johnson, R. S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3005 · Cited by 1,579
Akt Stimulates Aerobic Glycolysis in Cancer Cells
Elstrom, R. L., Bauer, D. E., Buzzai, M., Karnauskas, R., Harris, M. H., Plas, D. R., Zhuang, H., Cinalli, R. M., Alavi, A., Rudin, C. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2904 · Cited by 1,454
The impact of O2 availability on human cancer
Bertout, J. A., Patel, S. A., & Simon, M. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2540 · Cited by 1,365 · cited 1×
“Th is metabolic adaptation during the process of malignant transformation and tumorigenesis enables malignant cells to proliferate under low oxygen conditions (Bertout et al. 2008).”
BackgroundHypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells
Li, Z., Bao, S., Wu, Q., Wang, H., Eyler, C., Sathornsumetee, S., Shi, Q., Cao, Y., Lathia, J., McLendon, R. E., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.018 · Cited by 1,354 · cited 2×
“Moreover, they identifi ed HIF-2 α as biomarker that can predict clinical outcome and the response of glioblastoma patients to antiangiogenic therapies, such as anti-VEGF-antibody bevacizumab (Sathornsumetee et al. 2008, Li et al. 2009).”
BackgroundBerra, E., Benizri, E., Ginouvès, A., Volmat, V., Roux, D., & Pouysségur, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg392 · Cited by 1,348
Talks, K. L., Turley, H., Gatter, K. C., Maxwell, P. H., Pugh, C. W., Ratcliffe, P. J., & Harris, A. L. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64554-3 · Cited by 1,312
A tumorigenic subpopulation with stem cell properties in melanomas
Fang, D., Nguyen, T. K., Leishear, K., Finko, R., Kulp, A. N., Hotz, S., Van Belle, P. A., Xu, X., Elder, D. E., & Herlyn, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1343 · Cited by 1,280
Hypoxia-Inducible Factors, Stem Cells, and Cancer
Keith, B., & Simon, M. C. (2007) · Cell · doi:10.1016/j.cell.2007.04.019 · Cited by 1,179
Hypoxia, DNA repair and genetic instability
Bristow, R. G., & Hill, R. P. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2344 · Cited by 1,140 · cited 3×
“Th is might be an eff ect of hypoxia-induced altered cell cycle checkpoint control and abnormal DNA repair pathways (Coquelle et al. 1998, Bristow and Hill 2008, Kumareswaran et al. 2012).”
BackgroundInfluentialSelf-citationLinks between metabolism and cancer
Dang, C. V. (2012) · Genes & Development · doi:10.1101/gad.189365.112 · Cited by 1,100
Retinoic Acid Synthesis and Signaling during Early Organogenesis
Duester, G. (2008) · Cell · doi:10.1016/j.cell.2008.09.002 · Cited by 1,098
Hypoxia-inducible factor 1: master regulator of O2 homeostasis
Semenza, G. L. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80016-6 · Cited by 1,092
Tumor suppressors and cell metabolism: a recipe for cancer growth
Jones, R. G., & Thompson, C. B. (2009) · Genes & Development · doi:10.1101/gad.1756509 · Cited by 1,085
Maxwell, P. H., Dachs, G. U., Gleadle, J. M., Nicholls, L. G., Harris, A. L., Stratford, I. J., Hankinson, O., Pugh, C. W., & Ratcliffe, P. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.8104 · Cited by 1,084
Mitophagy: mechanisms, pathophysiological roles, and analysis
Ding, W.-X., & Yin, X.-M. (2012) · bchm · doi:10.1515/hsz-2012-0119 · Cited by 1,032 · cited 1×
“…under hypoxic conditions and the generation of ROS are inducers of mitophagy, the clearance of mitochondria, which has an additional anti-oxidative and protective eff ect on the malignant cells and is extending cellular life span (Zhang et al. 2008, Zhang and Ney 2009, Ding and Yin 2012).”
BackgroundRole of BNIP3 and NIX in cell death, autophagy, and mitophagy
Zhang, J., & Ney, P. A. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2009.16 · Cited by 1,021 · cited 1×
“…under hypoxic conditions and the generation of ROS are inducers of mitophagy, the clearance of mitochondria, which has an additional anti-oxidative and protective eff ect on the malignant cells and is extending cellular life span (Zhang et al. 2008, Zhang and Ney 2009, Ding and Yin 2012).”
BackgroundRadiation activates HIF-1 to regulate vascular radiosensitivity in tumors
Moeller, B. J., Cao, Y., Li, C. Y., & Dewhirst, M. W. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00115-1 · Cited by 996
Semenza, G. L., Nejfelt, M. K., Chi, S. M., & Antonarakis, S. E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.13.5680 · Cited by 990 · cited 1×
“Th e highly conserved transcriptional complex HIF-1 was fi rst identifi ed as a regulator of the hormone erythropoietin controlling red blood cell production (Goldberg et al. 1988, Semenza et al. 1991).”
BackgroundGuzy, R. D., & Schumacker, P. T. (2006) · Experimental Physiology · doi:10.1113/expphysiol.2006.033506 · Cited by 881 · cited 1×
“In addition, mitochondrial reactive oxygen species (ROS) are increased under hypoxic conditions and are capable of inactivating PHD enzymes (Jaakkola et al. 2001, Guzy and Schumacker 2006, Chua et al. 2010).”
BackgroundChemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL
Staller, P., Sulitkova, J., Lisztwan, J., Moch, H., Oakeley, E. J., & Krek, W. (2003) · Nature · doi:10.1038/nature01874 · Cited by 870 · cited 1×
“…the expression of the chemokine receptor CXCR4 is also activated under hypoxic conditions and might induce angiogenesis as well as metastasis (Staller et al. 2003) (the predictive role of CXCR4 is further discussed in this issue by Trautmann et al. entitled CXCR4 as biomarker for…”
BackgroundLoss of PTEN facilitates HIF-1-mediated gene expression
Zundel, W., Schindler, C., Haas-Kogan, D., Koong, A., Kaper, F., Chen, E., Gottschalk, A. R., Ryan, H. E., Johnson, R. S., Jefferson, A. B., et al. (2000) · Genes & Development · doi:10.1101/gad.14.4.391 · Cited by 840 · cited 2×
“…(e.g., TGF- β , interleukin 1), mitochondrial dysfunction (e.g., fumarate hydratase, succinate dehydrogenase) and environmental stimuli (e.g., nitric oxide, NF- κ B, pH value, nutrient deprivation) (Richard et al. 1999, Sodhi et al. 2000, Zundel et al. 2000, Minet et al. 2001, Rius et al. 2008).”
BackgroundOncogenic BRAF Regulates Oxidative Metabolism via PGC1α and MITF
Haq, R., Shoag, J., Andreu-Perez, P., Yokoyama, S., Edelman, H., Rowe, G. C., Frederick, D. T., Hurley, A. D., Nellore, A., Kung, A. L., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.02.003 · Cited by 818 · cited 1×
“We observed that ALDH FaDu cells show high ROS production as compared to nonALDH-active cells, suggesting an induction of oxidative stress possibly by up-regulated OXPHOS, which has recently been shown to link to neoplastic formation in melanoma (Haq et al. 2013, Vazquez et al. 2013).”
BackgroundThe role of hypoxia-inducible factors in tumorigenesis
Rankin, E. B., & Giaccia, A. J. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.21 · Cited by 806 · cited 1×
“Th at regulates the transcription of genes, which are involved in angiogenesis, metabolism, proliferation, invasion and metastasis to maintain oxygen homeostasis and to gain additional growth advantage (Rankin and Giaccia 2008).”
BackgroundMaltepe, E., Schmidt, J. V., Baunoch, D., Bradfield, C. A., & Simon, M. C. (1997) · Nature · doi:10.1038/386403a0 · Cited by 781 · cited 2×
“…[Ras] protein family, and c-myc) and loss-of-function mutations in tumor-suppressor genes (e.g., von Hippel-Lindau, phosphatase and tensin homolog [PTEN], tumor protein p53) as well as by other microenvi- ronmental cues such as the pH value and the availability of nutrients (Maltepe et al. 1997).”
BackgroundHIF-2α Promotes Hypoxic Cell Proliferation by Enhancing c-Myc Transcriptional Activity
Gordan, J. D., Bertout, J. A., Hu, C.-J., Diehl, J. A., & Simon, M. C. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.006 · Cited by 781
Holmquist-Mengelbier, L., Fredlund, E., Löfstedt, T., Noguera, R., Navarro, S., Nilsson, H., Pietras, A., Vallon-Christersson, J., Borg, Å., Gradin, K., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.026 · Cited by 735
Regulation of hypoxia-inducible factor-1α by NF-κB
van Uden, P., Kenneth, N. S., & Rocha, S. (2008) · Biochemical Journal · doi:10.1042/bj20080476 · Cited by 729
Detection and Characterization of Tumor Hypoxia Using pO 2 Histography
Vaupel, P., Höckel, M., & Mayer, A. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1628 · Cited by 728
Hypoxia and hypoxia-inducible factors: master regulators of metastasis
Lu, X., & Kang, Y. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1360 · Cited by 723
Vazquez, F., Lim, J.-H., Chim, H., Bhalla, K., Girnun, G., Pierce, K., Clish, C. B., Granter, S. R., Widlund, H. R., Spiegelman, B. M., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2012.11.020 · Cited by 715
Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α
Soeda, A., Park, M., Lee, D., Mintz, A., Androutsellis-Theotokis, A., McKay, R. D., Engh, J., Iwama, T., Kunisada, T., Kassam, A. B., et al. (2009) · Oncogene · doi:10.1038/onc.2009.252 · Cited by 656
DNA double-strand break repair: From mechanistic understanding to cancer treatment
HELLEDAY, T., LO, J., VANGENT, D., & ENGELWARD, B. (2007) · DNA Repair · doi:10.1016/j.dnarep.2007.02.006 · Cited by 640 · cited 1×
“Furthermore, hypoxia decreases Rec A recombinase (RAD51) protein level and thereby suppresses DNA repair through homologous recombination (HR) (Bindra et al. 2004, Helleday et al. 2007).”
BackgroundHypoxic Radiosensitization: Adored and Ignored
Overgaard, J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.7878 · Cited by 619
Imaging hypoxia to improve radiotherapy outcome
Horsman, M. R., Mortensen, L. S., Petersen, J. B., Busk, M., & Overgaard, J. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.171 · Cited by 614 · cited 1×
“…is the combination of imaging the hypoxic areas within the bulk tumor using a hypoxia-specifi c PET tracer with hypoxia-targeting strategies, such as image guided intensity-modulated radiotherapy (IMRT) (Rajendran et al. 2006, Le et al. 2010, Horsman et al. 2012, Th orwarth et al. 2013).”
MethodSynthetic lethal metabolic targeting of cellular senescence in cancer therapy
Dörr, J. R., Yu, Y., Milanovic, M., Beuster, G., Zasada, C., Däbritz, J. H. M., Lisec, J., Lenze, D., Gerhardt, A., Schleicher, K., et al. (2013) · Nature · doi:10.1038/nature12437 · Cited by 541 · cited 1×
“Th ose senescent cells were shown to be selectively assailable by feeding them a false substrate instead of glucose or by selectively inhibiting diff erent steps in the energy-generating pathway (D ö rr et al. 2013).”
BackgroundRegulation of tumor pH and the role of carbonic anhydrase 9
Swietach, P., Vaughan-Jones, R. D., & Harris, A. L. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9064-0 · Cited by 539 · cited 1×
“Acidic products of the aerobic glycolysis, lactic and bicarbonic acids, are secreted by the cancer cells and lead to acidic microenvironmental conditions, which facilitate invasive and immune suppressive properties of the tumor (Koukourakis et al. 2006, Fischer et al. 2007, Swietach et al. 2007).”
BackgroundKrohn, K. A., Link, J. M., & Mason, R. P. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.045914 · Cited by 506
Tumor hypoxia and malignant progression
Vaupel, P., Mayer, A., & Höckel, M. (2004) · Methods in Enzymology · doi:10.1016/s0076-6879(04)81023-1 · Cited by 496
Peng, J., Zhang, L., Drysdale, L., & Fong, G.-H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.140087397 · Cited by 460 · cited 1×
“Th ese mice are embryonic lethal, because of severe vascular defects, abnormal neural folding and cardiovascular malformation (Maltepe et al. 1997, Iyer et al. 1998, Ryan et al. 1998, Peng et al. 2000).”
BackgroundHypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation
Wong, C. C.-L., Gilkes, D. M., Zhang, H., Chen, J., Wei, H., Chaturvedi, P., Fraley, S. I., Wong, C.-M., Khoo, U.-S., Ng, I. O.-L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113483108 · Cited by 437
Mitochondrial complex III regulates hypoxic activation of HIF
Klimova, T., & Chandel, N. S. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402307 · Cited by 433 · cited 1×
“In general, around 60% of solid tumor tissue has an overall lower oxygen content (median pO 2 10 mmHg) as compared to benign normal tissue Klimova and Chandel 2008).”
BackgroundJögi, A., Øra, I., Nilsson, H., Lindeheim, Å., Makino, Y., Poellinger, L., Axelson, H., & Påhlman, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102660199 · Cited by 399
Koh, M. Y., Lemos, R., Liu, X., & Powis, G. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4142 · Cited by 350 · cited 1×
“…invasion (such as matrix metalloproteases [MMP] and plasminogen activator inhibitor-1 [PAI-1]), angiogenesis (VEGF) and stemness (such as octamer binding transcription factor 4 [Oct-4] and myelocytomatosis viral oncogene homolog [c-myc]) (Covello et al. 2006, Gordan et al. 2007, Koh et al. 2011).”
BackgroundVitamin A and retinoic acid in T cell-related immunity
Ross, A. C. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.034637 · Cited by 261 · cited 1×
“RA was described to guide embryonic development, angiogenesis, and suppression of infl ammatory reactions (Duester 2008, Ross 2012).”
BackgroundSivridis, E., Giatromanolaki, A., Gatter, K. C., Harris, A. L., Koukourakis, M. I., & for the Tumor and Angiogenesis Research Group (2002) · Cancer · doi:10.1002/cncr.10774 · Cited by 218 · cited 1×
“A strong nuclear HIF-1 expression in cancer was found to correlate with treatment failure, metastasis and increased mortality (Zhong et al. 1999, Talks et al. 2000, Maxwell et al. 2001, Sivridis et al. 2002, Winter et al. 2006) (Figure 4C –”
BackgroundChua, Y. L., Dufour, E., Dassa, E. P., Rustin, P., Jacobs, H. T., Taylor, C. T., & Hagen, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.158485 · Cited by 189 · cited 1×
“In addition, mitochondrial reactive oxygen species (ROS) are increased under hypoxic conditions and are capable of inactivating PHD enzymes (Jaakkola et al. 2001, Guzy and Schumacker 2006, Chua et al. 2010).”
BackgroundMitochondrial regulation of oxygen sensing
Bell, E. L., Emerling, B. M., & Chandel, N. S. (2005) · Mitochondrion · doi:10.1016/j.mito.2005.06.005 · Cited by 130
CD24 Is an Effector of HIF-1–Driven Primary Tumor Growth and Metastasis
Thomas, S., Harding, M. A., Smith, S. C., Overdevest, J. B., Nitz, M. D., Frierson, H. F., Tomlins, S. A., Kristiansen, G., & Theodorescu, D. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3666 · Cited by 128
Targeting hypoxic tumour cells to overcome metastasis
Bennewith, K. L., & Dedhar, S. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-504 · Cited by 109 · cited 1×
“…support angiogenesis, lymphangiogenesis, and metastasis (Semenza providing homing signals and growth and survival factors (Psaila and Lyden 2009) as well as angiogenic and immunsuppressive signals required for clonal expansion (Psaila and Lyden 2009, Bennewith and Dedhar 2011, Semenza 2013).”
Background
Cited by
Wang, H., Mu, X., He, H., & Zhang, X.-D. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.11.003 · Cited by 572
Molecular mechanisms of tumor resistance to radiotherapy
Wu, Y., Song, Y., Wang, R., & Wang, T. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01801-2 · Cited by 527
Role of metabolism in cancer cell radioresistance and radiosensitization methods
Tang, L., Wei, F., Wu, Y., He, Y., Shi, L., Xiong, F., Gong, Z., Guo, C., Li, X., Deng, H., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0758-7 · Cited by 409
ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance
Begicevic, R.-R., & Falasca, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112362 · Cited by 395
Cancer stem cells: The root of tumor recurrence and metastases
Peitzsch, C., Tyutyunnykova, A., Pantel, K., & Dubrovska, A. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.02.011 · Cited by 372
Self-citation
Metadata
- Authors
- Peitzsch, C., Perrin, R., Hill, R. P., Dubrovska, A., & Kurth, I.
- Venue
- International Journal of Radiation Biology
- Publisher
- Informa UK Limited
- Published
- 2014-06-25
- Volume
- 90
- Issue
- 8
- Pages
- 636-652
- ISSN
- 0955-3002 (ISSN-L)
- 1362-3095
- OpenAlex
- W2122979149
- Cited by
- 140
- References
- 71
- FWCI
- 4.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.